1. Academy of Medical Sciences (2015a) Stratified, personalised or P4 medicine: a new direction for placing the patient at the centre of healthcare and health education (Technical report). Academy of Medical Sciences. May 2015
2. Academy of Medical Sciences (2015b) Stratified, personalised or P4 medicine: a new direction for placing the patient at the centre of healthcare and health education [Online]. University of Southampton Council; Science Europe; Medical Research Council. https://acmedsci.ac.uk/viewFile/564091e072d41.pdf. Zugegriffen am 01.12.2017
3. Petrucelli N, Daly MB, Pal T (1998) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer [Online]. https://www.ncbi.nlm.nih.gov/pubmed/20301425. Zugegriffen am 01.12.2017
4. Papadaki C, Sfakianaki M, Ioannidis G, Lagoudaki E, Trypaki M, Tryfonidis K, Mavroudis D, Stathopoulos E, Georgoulias V, Souglakos J (2012) ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer. J Thorac Oncol 7(4):663–671
5. breastcancer.org (2017) HER2 status [Online]. http://www.breastcancer.org/symptoms/diagnosis/her2. Zugegriffen am 01.12.2017